Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chihiro Kondoh

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 24, 2018
[I. Dose-Dense Chemotherapy as Perioperative Treatment in Breast Cancer]Rika Kizawa, Yukinori Ozaki, Chihiro Kondoh, et al.
Gynecologic Oncology Reports|May 6, 2026
Pathological complete response following systemic therapy with carboplatin-paclitaxel plus pembrolizumab for initially unresectable mismatch repair-deficient advanced endometrial cancer: two case reportsNanami Uetake, Shiho Miura, Yurina Suzuki, et al.
Case Reports in Oncology|October 29, 2013
Complete Response to Trastuzumab-Based Chemotherapy in a Patient with Human Epidermal Growth Factor Receptor-2-Positive Metastatic Salivary Duct Carcinoma ex Pleomorphic AdenomaShigenori Kadowaki, Yasushi Yatabe, Hitoshi Hirakawa, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|April 17, 2018
Salvage chemotherapy with the combination of oxaliplatin, leucovorin, and 5-fluorouracil in advanced gastric cancer refractory or intolerant to fluoropyrimidines, platinum, taxanes, and irinotecanChihiro Kondoh, Shigenori Kadowaki, Azusa Komori, et al.
Breast Cancer (Tokyo, Japan)|January 23, 2018
Impact on disease-free survival of the duration of ovarian function suppression, as postoperative adjuvant therapy, in premenopausal women with hormone receptor-positive breast cancer: a retrospective single-institution studyYukinori Ozaki, Yuko Tanabe, Nobuko Tamura, et al.
BMC Palliative Care|August 5, 2015
Efficacy of palliative radiotherapy for gastric bleeding in patients with unresectable advanced gastric cancer: a retrospective cohort studyChihiro Kondoh, Kohei Shitara, Motoo Nomura, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 17, 2020
[Hypopituitarism]Taro Yamanaka, Keita Tatsushima, Chihiro Kondoh, et al.
International Journal of Radiation Oncology, Biology, Physics|March 15, 2012
Recursive partitioning analysis for new classification of patients with esophageal cancer treated by chemoradiotherapyMotoo Nomura, Kohei Shitara, Takeshi Kodaira, et al.
BMC Cancer|February 7, 2018
Changes in CT morphology can be an independent response marker for patients receiving regorafenib for colorectal liver metastases: retrospective pilot studyYukinori Ozaki, Junichi Shindoh, Wataru Gonoi, et al.
Molecular and Clinical Oncology|December 1, 2016
Muscle wasting associated with the long-term use of mTOR inhibitorsBishal Gyawali, Tomoya Shimokata, Kazunori Honda, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 24, 2018
[I. Dose-Dense Chemotherapy as Perioperative Treatment in Breast Cancer]Rika Kizawa, Yukinori Ozaki, Chihiro Kondoh, et al.
Gynecologic Oncology Reports|May 6, 2026
Pathological complete response following systemic therapy with carboplatin-paclitaxel plus pembrolizumab for initially unresectable mismatch repair-deficient advanced endometrial cancer: two case reportsNanami Uetake, Shiho Miura, Yurina Suzuki, et al.
Case Reports in Oncology|October 29, 2013
Complete Response to Trastuzumab-Based Chemotherapy in a Patient with Human Epidermal Growth Factor Receptor-2-Positive Metastatic Salivary Duct Carcinoma ex Pleomorphic AdenomaShigenori Kadowaki, Yasushi Yatabe, Hitoshi Hirakawa, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|April 17, 2018
Salvage chemotherapy with the combination of oxaliplatin, leucovorin, and 5-fluorouracil in advanced gastric cancer refractory or intolerant to fluoropyrimidines, platinum, taxanes, and irinotecanChihiro Kondoh, Shigenori Kadowaki, Azusa Komori, et al.
Breast Cancer (Tokyo, Japan)|January 23, 2018
Impact on disease-free survival of the duration of ovarian function suppression, as postoperative adjuvant therapy, in premenopausal women with hormone receptor-positive breast cancer: a retrospective single-institution studyYukinori Ozaki, Yuko Tanabe, Nobuko Tamura, et al.
BMC Palliative Care|August 5, 2015
Efficacy of palliative radiotherapy for gastric bleeding in patients with unresectable advanced gastric cancer: a retrospective cohort studyChihiro Kondoh, Kohei Shitara, Motoo Nomura, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 17, 2020
[Hypopituitarism]Taro Yamanaka, Keita Tatsushima, Chihiro Kondoh, et al.
International Journal of Radiation Oncology, Biology, Physics|March 15, 2012
Recursive partitioning analysis for new classification of patients with esophageal cancer treated by chemoradiotherapyMotoo Nomura, Kohei Shitara, Takeshi Kodaira, et al.
BMC Cancer|February 7, 2018
Changes in CT morphology can be an independent response marker for patients receiving regorafenib for colorectal liver metastases: retrospective pilot studyYukinori Ozaki, Junichi Shindoh, Wataru Gonoi, et al.
Molecular and Clinical Oncology|December 1, 2016
Muscle wasting associated with the long-term use of mTOR inhibitorsBishal Gyawali, Tomoya Shimokata, Kazunori Honda, et al.
Pageof 6